Inflammatory bowel disease activity assessment with biologic markers and 99mTc-WBC scintigraphy: Are there different trends in ileitis versus colitis?

Journal of Nuclear Medicine

Volumn 44, Issue 10, 2003, Pages 1586-1591

  Charron, Martin ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

99mTc labeled white blood cells; Assessment of intensity of inflammation in inflammatory bowel disease; Laboratory markers

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; HEMOGLOBIN; PROTEIN; TECHNETIUM 99M; TRACER; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT; TECHNETIUM;

ADOLESCENT; ARTICLE; CORRELATION COEFFICIENT; CROHN DISEASE; DISEASE MARKER; DRUG UPTAKE; ENTERITIS; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GASTROINTESTINAL TRACT SCINTISCANNING; HEMATOCRIT; HUMAN; ILEITIS; LABORATORY TEST; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THROMBOCYTE; ULCERATIVE COLITIS; BLOOD; CLASSIFICATION; CLINICAL TRIAL; COLITIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; GASTROINTESTINAL TRACT; HOSPITALIZATION; REFERENCE VALUE; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; STATISTICS; VASCULARIZATION;

ADOLESCENT; BIOLOGICAL MARKERS; COLITIS; CROHN DISEASE; DIAGNOSIS, DIFFERENTIAL; FEMALE; GASTROINTESTINAL TRACT; HUMANS; ILEITIS; INFLAMMATORY BOWEL DISEASES; LEUKOCYTES; MALE; RADIOPHARMACEUTICALS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STATISTICS; TECHNETIUM;

EID: 0642341631     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Hodgson HJ The natural history of treated ulcerative colitis [editorial; comment]. Gastroenterology 1994;107:300-302
2. Lorig K, Lubeck D, Kraines RG, et al. Outcomes of self-help education for patients with arthritis Arthritis Rheum 1985;28:680-685.
3. Lorig KR, Mazonson PD, Holman HR. Evidence suggesting that health education for self-management in patients with chronic arthritis has sustained health benefits while reducing health care costs Arthritis Rheum. 1993;36:439-446
4. Farmer RG, Whelan G, Fazio VW. Long-term follow-up of patients with Crohn's disease relationship between the clinical pattern and prognosis. Gastroenterology. 1985;88:1818-1825
5. Sachar DB, Luppescu NE, Bodian C, et al. Erythrocyte sedimentation as a measure of Crohn's disease activity: opposite trends in ilcitis versus colitis J Clin Gastroenterol 1990;12:643-646
6. Sachar DB, Smith H, Chan S, et al Erythrocytic sedimentation rate as a measure of clinical activity in inflammatory bowel disease. J Clin Gastroenterol. 1986; 8:647-650.
7. Charron M, Orenstein SR, Bhargava S. Detection of inflammatory bowel disease in pediatric patients with technetium-99m-HMPAO-labeled leukocytes J Nucl Med. 1994;35:451-455.
8. Charron M, del Rosario JF, Kocoshis SA Characterization of late abdominal accumulation of 99Tcm-HMPAO leukocytes in a large population of children. Nucl Med Commun 1998;19:753-759.
9. Wallis JW, Miller TR. Volume rendering in three-dimensional display of SPECT images J Nucl Med. 1990;31:1421-1428
10. Tibble JA, Sigthorsson G, Foster R, et al. Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease Gastroenterology. 2002;123:450-460
11. Farmer RG, Hawk WA, Turnbull RB Jr Clinical patterns in Crohn's disease: a statistical study of 615 cases. Gastroenterology. 1975;68:627-635.
12. Whelan G, Farmer RG, Fazio VW, et al. Recurrence after surgery in Crohn's disease: relationship to location of disease (clinical pattern) and surgical indication. Gastroenterology. 1985;88:1826-1833.
13. Holdstock G, Savage D, Harman M, et al. An investigation into the validity of the present classification of inflammatory bowel disease. Q J Med 1985;54:183-190
14. Gasche C, Scholmerich J, Brynskov J, et al. A simple classification of Crohn's disease, report of the Working Party for the World Congresses of Gastroenterology. Vienna 1998. Inflamm Bowel Dis 2000;6:8-15.
15. Louis E, Collard A, Oger AF, et al. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut. 2001;49:777-782
16. Richter MB, Coughlan RJ, Panayi GS, et al. Is there more than one signal for an acute phase response? J Rheumatol 1985;12:1048-1052.
17. Bhargava SA, Orenstein SR, Charron M Technetium-99m hexamethylpropyleneamine-oxime-labeled leukocyte scintigraphy in inflammatory bowel disease in children. J Pediatr. 1994;125:213-217.
18. Papos M, Varkonyi A, Lang J, et al. HM-PAO-labeled leukocyte scintigraphy in pediatric patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1996;23:547-552.
19. Jewell FM, Davies A, Sandhu B, et al. Technetium-99m-HMPAO labelled leucocytes in the detection and monitoring of inflammatory bowel disease in children. Br J Radiol. 1996;69:508-514.
20. Jobling JC, Lindley KJ, Yousef Y, et al. Investigating inflammatory bowel disease: white cell scanning, radiology, and colonoscopy. Arch Dis Child. 1996; 74:22-26
21. Hyams JS, Ferry GD, Mandel FS, et al Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr. 1991;12:439-447.
22. Lloyd-Still JD, Green OC. A clinical scoring system for chronic inflammatory bowel disease in children. Dig Dis Sci. 1979;24:620-624.
23. Linskens RK, van Bodegraven AA, Schoorl M, et al Predictive value of inflammatory and coagulation parameters in the course of severe ulcerative colitis. Dig Dis Sci. 2001;46:644-648.
24. van Wersch JW, Houben P, Rijken J Platelet count, platelet function, coagulation activity and fibrinolysis in the acute phase of inflammatory bowel disease. J Clin Chem Clin Biochem. 1990;28:513-517.
25. Seo M, Okada M, Yao T, et al. An index of disease activity in patients with ulcerative colitis Am J Gastroenterol. 1992;87:971-976.
26. Holmquist L, Ahren C, Fallstrom SP. Relationship between results of laboratory tests and inflammatory activity assessed by colonoscopy in children and adolescents with ulcerative colitis and Crohn's colitis. J Pediatr Gastroenterol Nutr 1989;9:187-193.
27. Van Hees PAM, van Lier HJJ, van Elteren PH, et al Effect of sulphasalazine in patients with active Crohn's disease: a controlled double-blind study. Gut. 1981; 22:404-409.
28. Cooke WT, Prior P. Determining disease activity in inflammatory bowel disease. J Clin Gastroenterol. 1984;6:17-25.
29. Kambe H, Yoshida T, Haraguchi Y, Iwashita T, Sakamoto A, Tanaka K. Quantification of disease activity in patients with ulcerative colitis. J Clin Gastroenterol. 1986;8:651-654